CymaBay Therapeutics, Inc. (0I5P.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.53B |
| Enterprise Value | 2.44B |
| P/E Ratio | -32.74 |
| PEG Ratio | -1.1 |
| Price/Sales Ratio | 119.98 |
| Price/Book Ratio | 11.8 |
| Enterprise/Revenue | 117.02 |
| Enterprise/EBITDA | -42.41 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | December 31, 2023 |
| Profit Margin | -3.39 |
| Operating Margin | -3.27 |
| Return On Assets | -0.24 |
| Return On Equity | -0.64 |
| Revenue | 31.07M |
| Revenue/Share | 0.29 |
| Gross Profit | 30.39M |
| EBITDA | -85.74M |
| Net Income | -105.37M |
| Diluted EPS | -0.99 |
| Total Cash | 394.26M |
| Total Cash/Share | 3.71 |
| Total Debt | 114.49M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 10.96 |
| Book Value Per Share | 2.75 |
| 52-Week Change | 218.15 |
| 52-Week High | 32.48 |
| 52-Week Low | 32.48 |
| Moving Average 50 Days | 26.99 |
| Moving Average 200 Days | 17.16 |
| Average Volume | 2,721 |
| Shares Outstanding | 66.44M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |